Cefotaxime, Lidocaine

3 trials 2 recruiting JAnti-infectives

Filter these 3 trials by condition, phase, country and more.

Open in Search →

3 Registered trials

2 Recruiting

0 Completed trials

3 Sponsors

3 Countries

Phase II

Phase IV

Phase II: 1 Phase IV: 2

Indications tested

Antibiotic level therapeutic 1 Sepsis 1

Sponsors using this IMP

Akershus University Hospital 1 Centre Hospitalier Universitaire De Nantes 1 Uppsala Universitet 1

All trials

3 total

Defining Antibiotic Levels in Intensive care patients (DALI-2) protocol Pending

2024-516232-10-00 Phase IV 1 country Centre Hospitalier Universitaire De Nimes
Pivmecillinam as oral step-down treatment for Escherichia coli febrile urinary tract infection versus standard of care; a randomized control… Recruiting

2023-503447-33-00 Phase II 2 countries Uppsala Universitet
Aminoglycosides in early sepsis Recruiting

2024-519797-39-00 Phase IV 1 country Akershus University Hospital

Showing 1–3 of 3 trials

← All drugs A–Z